Case Study: AC Immune achieves improved data traceability and faster collaboration with Benchling

Pioneering precision medicine to diagnose, treat, and prevent neurodegeneration

AC Immune is a clinical‑stage biopharmaceutical company based in Lausanne, Switzerland, focused on precision medicine for neurodegenerative diseases such as Alzheimer’s and Parkinson’s. With ~150 employees and two proprietary platforms (SupraAntigen® for vaccines/antibodies and Morphomer® for small‑molecule therapeutics and imaging), the company needed to replace notebook- and spreadsheet-based workflows with a searchable, relational data system to improve standardization, traceability, and faster cross‑team collaboration.

By adopting Benchling as a centralized, cloud‑based source of truth, AC Immune standardized protocols, workflows, and schemas, enabled real‑time collaboration, and automated analysis and visualization to maintain FAIR data practices. The change improved traceability and data quality, saved scientists about 4 hours per week, 93% of users credited the partnership with better data storage and retrieval, and after six months 75% reported the unified system enhanced their ability to build machine‑learning models and generate scientific insights.

AC Immune

Marie Kosco-Vilbois

Chief Scientific Officer